| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 16 | 2025 | 76 | 3.040 |
Why?
|
| Coronary Artery Disease | 20 | 2025 | 395 | 2.990 |
Why?
|
| Shock, Cardiogenic | 20 | 2025 | 172 | 2.900 |
Why?
|
| Cardiac Catheterization | 14 | 2025 | 334 | 2.130 |
Why?
|
| Radial Artery | 7 | 2022 | 37 | 1.680 |
Why?
|
| Acute Coronary Syndrome | 5 | 2021 | 34 | 1.660 |
Why?
|
| Heart-Assist Devices | 12 | 2024 | 903 | 1.600 |
Why?
|
| Robotic Surgical Procedures | 8 | 2025 | 367 | 1.420 |
Why?
|
| Heart Failure | 18 | 2025 | 1438 | 1.360 |
Why?
|
| Coronary Angiography | 13 | 2024 | 262 | 1.320 |
Why?
|
| Coronary Vessels | 8 | 2024 | 200 | 1.090 |
Why?
|
| Myocardial Infarction | 12 | 2025 | 436 | 1.010 |
Why?
|
| Intra-Aortic Balloon Pumping | 5 | 2025 | 92 | 1.000 |
Why?
|
| Catheterization, Peripheral | 3 | 2022 | 64 | 0.980 |
Why?
|
| Angioplasty, Balloon, Coronary | 11 | 2018 | 67 | 0.930 |
Why?
|
| Hemodynamics | 7 | 2024 | 776 | 0.930 |
Why?
|
| Registries | 7 | 2025 | 998 | 0.930 |
Why?
|
| Ischemia | 4 | 2024 | 256 | 0.880 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2025 | 180 | 0.850 |
Why?
|
| Treatment Outcome | 41 | 2025 | 9228 | 0.820 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 218 | 0.820 |
Why?
|
| Endoscopy | 4 | 2025 | 374 | 0.780 |
Why?
|
| Pulmonary Embolism | 6 | 2021 | 236 | 0.740 |
Why?
|
| Coronary Artery Bypass | 9 | 2025 | 252 | 0.730 |
Why?
|
| Humans | 101 | 2025 | 95992 | 0.710 |
Why?
|
| Drug-Eluting Stents | 6 | 2025 | 22 | 0.710 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2019 | 100 | 0.700 |
Why?
|
| Retrospective Studies | 40 | 2025 | 10307 | 0.680 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2021 | 111 | 0.680 |
Why?
|
| Chitosan | 1 | 2021 | 17 | 0.680 |
Why?
|
| Hemorrhage | 4 | 2022 | 295 | 0.650 |
Why?
|
| Hemostatics | 1 | 2021 | 61 | 0.650 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 3 | 2020 | 42 | 0.640 |
Why?
|
| Blood Pressure | 2 | 2014 | 926 | 0.630 |
Why?
|
| Kidney | 3 | 2021 | 1135 | 0.620 |
Why?
|
| Brachial Artery | 2 | 2021 | 36 | 0.610 |
Why?
|
| Ultrasonography, Interventional | 3 | 2023 | 126 | 0.600 |
Why?
|
| Aged | 46 | 2025 | 20927 | 0.550 |
Why?
|
| Clinical Protocols | 1 | 2018 | 162 | 0.530 |
Why?
|
| Disease Management | 2 | 2018 | 363 | 0.530 |
Why?
|
| Hospital Mortality | 11 | 2025 | 485 | 0.530 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2017 | 9 | 0.510 |
Why?
|
| Aortic Valve Stenosis | 4 | 2023 | 169 | 0.500 |
Why?
|
| Coronary Restenosis | 5 | 2011 | 12 | 0.490 |
Why?
|
| Male | 57 | 2025 | 45792 | 0.490 |
Why?
|
| Septal Occluder Device | 5 | 2025 | 57 | 0.470 |
Why?
|
| Female | 55 | 2025 | 49980 | 0.460 |
Why?
|
| Upper Extremity | 1 | 2016 | 65 | 0.460 |
Why?
|
| Middle Aged | 45 | 2025 | 28299 | 0.450 |
Why?
|
| Heart Arrest | 4 | 2022 | 313 | 0.440 |
Why?
|
| Hypertension | 2 | 2014 | 775 | 0.440 |
Why?
|
| Denervation | 1 | 2014 | 25 | 0.440 |
Why?
|
| Mammary Arteries | 3 | 2023 | 34 | 0.440 |
Why?
|
| Cardiovascular System | 1 | 2014 | 64 | 0.420 |
Why?
|
| Emergency Service, Hospital | 3 | 2021 | 593 | 0.420 |
Why?
|
| Sympathectomy | 1 | 2013 | 19 | 0.410 |
Why?
|
| Femoral Artery | 4 | 2025 | 91 | 0.400 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2013 | 77 | 0.400 |
Why?
|
| Foramen Ovale, Patent | 2 | 2025 | 24 | 0.400 |
Why?
|
| Stents | 6 | 2024 | 422 | 0.380 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2023 | 199 | 0.380 |
Why?
|
| Thrombolytic Therapy | 5 | 2021 | 261 | 0.370 |
Why?
|
| Platelet Aggregation | 1 | 2012 | 42 | 0.360 |
Why?
|
| Blood Coagulation Tests | 1 | 2012 | 32 | 0.360 |
Why?
|
| Ticlopidine | 1 | 2012 | 26 | 0.360 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 133 | 0.340 |
Why?
|
| Heart Rate | 1 | 2013 | 533 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1096 | 0.340 |
Why?
|
| Heart Ventricles | 3 | 2021 | 826 | 0.330 |
Why?
|
| Myocardial Ischemia | 4 | 2024 | 167 | 0.330 |
Why?
|
| Angioplasty, Balloon | 4 | 2020 | 98 | 0.330 |
Why?
|
| Aorta | 3 | 2021 | 294 | 0.330 |
Why?
|
| Vascular Patency | 5 | 2023 | 127 | 0.320 |
Why?
|
| Chest Pain | 1 | 2010 | 49 | 0.320 |
Why?
|
| Popliteal Artery | 2 | 2020 | 30 | 0.320 |
Why?
|
| Absorbable Implants | 2 | 2020 | 37 | 0.310 |
Why?
|
| Coronary Disease | 4 | 2018 | 263 | 0.310 |
Why?
|
| Time Factors | 15 | 2025 | 5593 | 0.310 |
Why?
|
| Risk Factors | 13 | 2025 | 5992 | 0.300 |
Why?
|
| Heart Diseases | 2 | 2016 | 318 | 0.290 |
Why?
|
| Ventricular Function, Left | 4 | 2021 | 677 | 0.290 |
Why?
|
| Thrombosis | 2 | 2025 | 326 | 0.290 |
Why?
|
| Peripheral Arterial Disease | 2 | 2020 | 102 | 0.290 |
Why?
|
| Follow-Up Studies | 11 | 2025 | 3922 | 0.260 |
Why?
|
| Gastric Fundus | 1 | 2006 | 7 | 0.250 |
Why?
|
| Gastric Fistula | 1 | 2006 | 4 | 0.250 |
Why?
|
| Electrodes | 1 | 2006 | 103 | 0.240 |
Why?
|
| Pericardium | 1 | 2006 | 84 | 0.240 |
Why?
|
| Axillary Artery | 1 | 2025 | 12 | 0.230 |
Why?
|
| Aortic Valve | 3 | 2023 | 277 | 0.230 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2025 | 73 | 0.230 |
Why?
|
| Calcium Channel Blockers | 1 | 2005 | 123 | 0.230 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2019 | 248 | 0.220 |
Why?
|
| Brachiocephalic Veins | 2 | 2021 | 33 | 0.220 |
Why?
|
| Cardiovascular Agents | 2 | 2019 | 61 | 0.220 |
Why?
|
| Defibrillators, Implantable | 1 | 2006 | 190 | 0.210 |
Why?
|
| Triage | 2 | 2018 | 132 | 0.210 |
Why?
|
| Echocardiography, Three-Dimensional | 4 | 2019 | 528 | 0.210 |
Why?
|
| Anticoagulants | 3 | 2022 | 465 | 0.210 |
Why?
|
| Carotid Arteries | 1 | 2024 | 136 | 0.200 |
Why?
|
| Fibrinolytic Agents | 3 | 2021 | 240 | 0.200 |
Why?
|
| Hypothermia, Induced | 1 | 2024 | 91 | 0.200 |
Why?
|
| Cysteine | 1 | 2024 | 146 | 0.200 |
Why?
|
| Length of Stay | 4 | 2025 | 835 | 0.200 |
Why?
|
| Coronary Stenosis | 2 | 2019 | 39 | 0.200 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2015 | 144 | 0.190 |
Why?
|
| Kidney Diseases | 1 | 2005 | 323 | 0.190 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2022 | 15 | 0.190 |
Why?
|
| Foreign-Body Migration | 2 | 2017 | 34 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2019 | 364 | 0.190 |
Why?
|
| Microcirculation | 2 | 2024 | 104 | 0.180 |
Why?
|
| Device Removal | 2 | 2018 | 169 | 0.180 |
Why?
|
| Ulnar Artery | 1 | 2022 | 6 | 0.180 |
Why?
|
| Coronary Circulation | 2 | 2024 | 133 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2024 | 936 | 0.180 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 32 | 0.180 |
Why?
|
| Prognosis | 6 | 2025 | 3993 | 0.170 |
Why?
|
| Hemostasis | 1 | 2021 | 24 | 0.170 |
Why?
|
| Hemostatic Techniques | 1 | 2021 | 19 | 0.170 |
Why?
|
| Troponin T | 1 | 2021 | 44 | 0.170 |
Why?
|
| Prosthesis Design | 5 | 2024 | 311 | 0.170 |
Why?
|
| Arteriovenous Fistula | 1 | 2021 | 54 | 0.170 |
Why?
|
| Heart Atria | 3 | 2021 | 297 | 0.160 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2020 | 23 | 0.160 |
Why?
|
| Predictive Value of Tests | 7 | 2021 | 1819 | 0.150 |
Why?
|
| Risk Assessment | 9 | 2025 | 2498 | 0.150 |
Why?
|
| Survival Rate | 5 | 2024 | 1978 | 0.150 |
Why?
|
| Adult | 12 | 2025 | 28636 | 0.150 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2019 | 5 | 0.150 |
Why?
|
| Everolimus | 1 | 2019 | 36 | 0.150 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 135 | 0.150 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2019 | 72 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 258 | 0.150 |
Why?
|
| Stroke Volume | 2 | 2021 | 550 | 0.140 |
Why?
|
| Perioperative Care | 1 | 2021 | 188 | 0.140 |
Why?
|
| Atherectomy, Coronary | 1 | 2018 | 2 | 0.140 |
Why?
|
| Cardiac Catheters | 1 | 2018 | 20 | 0.140 |
Why?
|
| Electrocardiography | 2 | 2011 | 559 | 0.140 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 169 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2021 | 364 | 0.140 |
Why?
|
| Hospital Costs | 1 | 2019 | 117 | 0.140 |
Why?
|
| Monocytes | 1 | 2019 | 219 | 0.140 |
Why?
|
| Microvessels | 1 | 2018 | 69 | 0.130 |
Why?
|
| Social Determinants of Health | 1 | 2019 | 111 | 0.130 |
Why?
|
| Prevalence | 4 | 2025 | 1355 | 0.130 |
Why?
|
| Vascular Calcification | 1 | 2018 | 54 | 0.130 |
Why?
|
| Catheters | 3 | 2023 | 96 | 0.130 |
Why?
|
| Blood Circulation | 1 | 2017 | 31 | 0.130 |
Why?
|
| Heart Massage | 1 | 2017 | 12 | 0.130 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2019 | 103 | 0.130 |
Why?
|
| Heart Transplantation | 1 | 2023 | 816 | 0.130 |
Why?
|
| Renal Veins | 1 | 2017 | 27 | 0.130 |
Why?
|
| United States | 9 | 2024 | 7785 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2021 | 1158 | 0.130 |
Why?
|
| Severity of Illness Index | 8 | 2019 | 1982 | 0.120 |
Why?
|
| Equipment Failure | 3 | 2018 | 133 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 186 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2017 | 1541 | 0.120 |
Why?
|
| Health Status Disparities | 1 | 2019 | 221 | 0.120 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 74 | 0.120 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 334 | 0.120 |
Why?
|
| Biomarkers | 2 | 2021 | 1931 | 0.120 |
Why?
|
| Vena Cava Filters | 1 | 2017 | 90 | 0.120 |
Why?
|
| Organ Dysfunction Scores | 1 | 2016 | 34 | 0.120 |
Why?
|
| Rest | 1 | 2016 | 53 | 0.120 |
Why?
|
| Macrophages | 1 | 2019 | 620 | 0.120 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2016 | 48 | 0.120 |
Why?
|
| Catheterization | 1 | 2017 | 237 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 151 | 0.110 |
Why?
|
| Atrial Appendage | 1 | 2015 | 42 | 0.110 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 444 | 0.110 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 519 | 0.100 |
Why?
|
| Forecasting | 1 | 2014 | 317 | 0.100 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2006 | 100 | 0.100 |
Why?
|
| Age Factors | 4 | 2021 | 1959 | 0.100 |
Why?
|
| Software | 1 | 2017 | 698 | 0.100 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2013 | 62 | 0.090 |
Why?
|
| Comorbidity | 3 | 2025 | 1017 | 0.090 |
Why?
|
| Epigastric Arteries | 1 | 2012 | 9 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 700 | 0.090 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2012 | 7 | 0.090 |
Why?
|
| Academic Medical Centers | 3 | 2021 | 422 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2885 | 0.090 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 7224 | 0.090 |
Why?
|
| Operative Time | 2 | 2025 | 168 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2012 | 122 | 0.090 |
Why?
|
| Catheter Ablation | 1 | 2015 | 365 | 0.090 |
Why?
|
| Vascular Resistance | 2 | 2024 | 104 | 0.090 |
Why?
|
| Mitral Valve | 1 | 2013 | 280 | 0.080 |
Why?
|
| Prospective Studies | 6 | 2022 | 4690 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2012 | 156 | 0.080 |
Why?
|
| Acute Disease | 2 | 2024 | 859 | 0.080 |
Why?
|
| Punctures | 2 | 2021 | 29 | 0.080 |
Why?
|
| Platelet Activation | 1 | 2010 | 18 | 0.080 |
Why?
|
| Coronary Aneurysm | 1 | 2010 | 16 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 273 | 0.080 |
Why?
|
| Mammaplasty | 1 | 2012 | 124 | 0.080 |
Why?
|
| Thoracic Injuries | 1 | 2010 | 41 | 0.080 |
Why?
|
| Surgical Flaps | 1 | 2012 | 259 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 2777 | 0.080 |
Why?
|
| Sirolimus | 1 | 2010 | 177 | 0.070 |
Why?
|
| Hospitals | 2 | 2022 | 329 | 0.070 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2003 | 11 | 0.070 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 118 | 0.070 |
Why?
|
| Medically Uninsured | 1 | 2009 | 67 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2010 | 488 | 0.070 |
Why?
|
| Minority Groups | 1 | 2009 | 154 | 0.070 |
Why?
|
| Illinois | 4 | 2018 | 530 | 0.070 |
Why?
|
| Pulsatile Flow | 2 | 2021 | 52 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2019 | 935 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2009 | 239 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 491 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2011 | 502 | 0.070 |
Why?
|
| Chicago | 3 | 2021 | 1505 | 0.060 |
Why?
|
| Thoracotomy | 1 | 2006 | 68 | 0.060 |
Why?
|
| Brachytherapy | 2 | 2004 | 127 | 0.060 |
Why?
|
| Saphenous Vein | 1 | 2006 | 61 | 0.060 |
Why?
|
| Embolism | 1 | 2006 | 34 | 0.060 |
Why?
|
| Beta Particles | 2 | 2003 | 4 | 0.060 |
Why?
|
| Strontium Radioisotopes | 2 | 2003 | 4 | 0.060 |
Why?
|
| Postoperative Complications | 3 | 2022 | 2603 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 997 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 333 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2019 | 983 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 500 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2019 | 287 | 0.050 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2015 | 107 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2006 | 255 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3642 | 0.050 |
Why?
|
| Angina, Unstable | 1 | 2003 | 6 | 0.050 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2003 | 32 | 0.050 |
Why?
|
| Extremities | 1 | 2024 | 179 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 129 | 0.050 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2003 | 25 | 0.050 |
Why?
|
| Spasm | 1 | 2022 | 19 | 0.050 |
Why?
|
| Sternotomy | 1 | 2022 | 24 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2022 | 90 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2019 | 1014 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 1018 | 0.040 |
Why?
|
| Myocardial Revascularization | 3 | 2009 | 32 | 0.040 |
Why?
|
| Ventricular Pressure | 1 | 2021 | 48 | 0.040 |
Why?
|
| Pulmonary Veins | 1 | 2002 | 111 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1962 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2023 | 341 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2002 | 240 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2021 | 98 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 201 | 0.040 |
Why?
|
| Torsion, Mechanical | 1 | 2020 | 6 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2021 | 219 | 0.040 |
Why?
|
| Limb Salvage | 1 | 2020 | 38 | 0.040 |
Why?
|
| Pulmonary Valve | 1 | 2020 | 36 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 281 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2020 | 159 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2023 | 542 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 376 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2019 | 140 | 0.040 |
Why?
|
| Bioprosthesis | 1 | 2019 | 43 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1561 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 107 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 236 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 166 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 3155 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 721 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 157 | 0.030 |
Why?
|
| Sex Factors | 1 | 2021 | 1130 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 946 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2019 | 479 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 258 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 248 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2017 | 18 | 0.030 |
Why?
|
| Reoperation | 1 | 2020 | 712 | 0.030 |
Why?
|
| Equipment Design | 1 | 2018 | 435 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 631 | 0.030 |
Why?
|
| Incidence | 3 | 2010 | 1723 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 318 | 0.030 |
Why?
|
| Phlebography | 1 | 2017 | 68 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 708 | 0.030 |
Why?
|
| Oxygen | 1 | 2021 | 781 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 386 | 0.030 |
Why?
|
| Cannula | 1 | 2016 | 57 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2003 | 239 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 303 | 0.030 |
Why?
|
| Purines | 1 | 2016 | 97 | 0.030 |
Why?
|
| Animals | 1 | 2014 | 28901 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1741 | 0.030 |
Why?
|
| Echocardiography | 1 | 2020 | 1010 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2016 | 161 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2009 | 600 | 0.030 |
Why?
|
| Contrast Media | 1 | 2019 | 1097 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 1810 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2017 | 565 | 0.030 |
Why?
|
| Recurrence | 2 | 2009 | 1231 | 0.020 |
Why?
|
| Adenosine | 1 | 2016 | 278 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 2013 | 107 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2042 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2013 | 123 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2015 | 747 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 675 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2011 | 29 | 0.020 |
Why?
|
| Workflow | 1 | 2011 | 80 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 365 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 419 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 323 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2010 | 104 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 221 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 7034 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 2018 | 0.020 |
Why?
|
| Violence | 1 | 2010 | 154 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 890 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 458 | 0.020 |
Why?
|
| Preventive Medicine | 1 | 2006 | 19 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 1273 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 157 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2004 | 37 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 162 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 66 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2003 | 59 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 297 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 236 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2002 | 92 | 0.010 |
Why?
|
| Angiography | 1 | 2002 | 209 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 823 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 321 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2002 | 152 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2006 | 3115 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 9878 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 1166 | 0.010 |
Why?
|